DOUBLE HEMIBODY IRRADIATION (DHBI) WITH HRGM-CSF SUPPORT VS MELPHALANPREDNISONE (MP) IN PATIENTS GREATER-THAN 55 YEARS WITH STAGE-III MULTIPLE-MYELOMA (MM) - A RANDOMIZED TRIAL
M. Macro et al., DOUBLE HEMIBODY IRRADIATION (DHBI) WITH HRGM-CSF SUPPORT VS MELPHALANPREDNISONE (MP) IN PATIENTS GREATER-THAN 55 YEARS WITH STAGE-III MULTIPLE-MYELOMA (MM) - A RANDOMIZED TRIAL, Blood, 88(10), 1996, pp. 3611-3611